Cardiac surgery was the last area of surgery to become “minimally invasive,” and this began in the mid-1990s with some regularity at the Cleveland Clinic and the Brigham and Women's Hospital.
The objective of this study was to describe and evaluate the adjunctive technique of Angio-Seal (AS) use to augment the dual Perclose ProGlide (PP) in achieving haemostasis in patients undergoing transfemoral percutaneous transcatheter aortic valve replacement (TAVR).